Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
citric acid (1 trial)
clarithromycin (biaxin) (1 trial)
magnesium oxide (1 trial)
metronidazole (flagyl) (1 trial)
midazolam (versed) (1 trial)
omeprazole (prilosec) (1 trial)
procaine benzylpenicillin (novocaine) (1 trial)
propofol (diprivan) (1 trial)
sodium picosulfate (1 trial)
cyclosporine (sandimmune) (1 trial)
mycophenolate (myfortic) (1 trial)
prednisone (meticorten) (1 trial)
azacitidine (vidaza) (1 trial)
cytarabine (cytosar-u) (1 trial)
quizartinib (1 trial)
venetoclax (venclexta) (1 trial)
Leukemia (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Lupus Nephritis (Phase 3)
Nephritis (Phase 3)
Trials (5 total)
Trial APIs (16 total)